Ipamorelin
5mg — 5mg vial
Batch-tested quality with pricing built around repeat research orders.
Research Use Only. This product is intended for research and laboratory use only. Not for human consumption. Not a dietary supplement. No therapeutic claims are made or implied. By purchasing, you confirm this product is for legitimate research purposes.
Product Details
Selective growth hormone secretagogue pentapeptide that stimulates GH release from the pituitary through the GHS-R (ghrelin receptor) without significantly affecting cortisol or prolactin levels. This selectivity is ipamorelin's primary distinguishing feature compared to earlier GH secretagogues like GHRP-6 and GHRP-2.
The peptide binds GHS-R1a, triggering intracellular calcium signalling and dose-dependent GH release with a clear ceiling effect. When co-administered with GHRH analogues such as Mod GRF 1-29, the GH response is amplified beyond additive effects, as the two pathways converge on different intracellular mechanisms in pituitary somatotrophs.
Common research applications include growth hormone axis pharmacology, body composition studies, bone mineral density research, GH secretagogue receptor characterisation, and age-related GH decline models. The selectivity provides a cleaner pharmacological probe for studying GH-specific effects without the confounds of concurrent cortisol elevation and appetite stimulation.
Storage Instructions
- Store lyophilised powder at -20°C for long-term stability
- Reconstituted solution: 2–8°C, use within 2–4 weeks
- Protect from light and moisture
- Shipped with cold packs for temperature stability
Specifications
>98% (HPLC)
Lyophilised powder
5mg
5mg vial
